At MAXi Technology Group, Research, Development & Innovation (RD&I) is more than a business function—it is the foundation of our global strategy for creating transformative technologies, intellectual property and scalable solutions capable of addressing complex challenges across healthcare, life sciences, advanced manufacturing, sustainability and industrial innovation.

​

As a Global Deep Tech Group, MAXi operates through an integrated international innovation ecosystem connecting the United States, Brazil and Portugal. This structure enables the convergence of scientific excellence, industrial capabilities, entrepreneurial vision and global capital, creating a unique environment for the development, validation, scale-up and commercialization of breakthrough technologies.

​

Our RD&I activities are designed to bridge the gap between scientific discovery and market adoption, transforming research into products, industrial processes, technology platforms, licensing opportunities and high-impact ventures.

​

A Global Innovation Ecosystem

​

MAXi's innovation model is based on the belief that the most relevant technological breakthroughs emerge through collaboration.

Through its international structure, MAXi connects scientific institutions, universities, innovation centers, startups, corporations, investors and government-supported research programs into a single collaborative ecosystem.

​

The Group operates through:

​

United States

MAXi Technology and Science LLC (Delaware)

​

The U.S. operation serves as the Group's global headquarters and international business platform, supporting:

• International technology commercialization

• Intellectual property management

• Strategic partnerships

• Technology licensing

• Venture development

• Global investment attraction

• Access to North American innovation ecosystems

​

The U.S. structure enables international investors, corporations and research organizations to participate in technology development programs originated in Brazil and Europe while facilitating global market access for technologies developed by MAXi.

​

Brazil

Research, Development & Industrial Innovation Operations

​

Brazil represents the scientific and technological foundation of the Group.

The country hosts the majority of our research programs, pilot developments, proof-of-concept projects and technology validation activities.

Through strong collaboration with research institutions, innovation agencies and industrial partners, Brazil serves as a strategic platform for developing technologies based on advanced materials, nanotechnology, bionanotechnology and biotechnology.

​

Many of our technologies are designed to transform the country's rich biodiversity, renewable biomass resources and scientific capabilities into globally competitive innovation assets.

​

Portugal

DR&I Center and European Innovation & Technology Commercialization Hub

​

Portugal acts as MAXi's gateway to the European innovation ecosystem.

The operation is being structured to facilitate:

• European collaborative research projects

• Access to Horizon Europe programs

• Technology transfer initiatives

• Industrial partnerships

• International business development

• European market expansion

​

Portugal also provides a strategic bridge connecting Latin American innovation with European research institutions, investors and industrial networks.

​

Research Areas

​

MAXi develops technologies through a multidisciplinary approach integrating materials science, nanotechnology, biotechnology, engineering, healthcare and industrial innovation.

Advanced Materials & Industrial Bioeconomy

Development of advanced materials obtained from renewable biomass and industrial by-products.

​

Key technologies include:

• Graphene and graphene derivatives

• Graphene oxide

• Reduced graphene oxide

• Amorphous carbon

• Nanocellulose

• Activated liquid carbon

• Advanced composites

• Functional materials

​

Current projects include the development of graphene oxide, amorphous carbon and fiber-reinforced composites derived from sugarcane biomass, as well as next-generation graphene and nanocellulose technologies derived from eucalyptus biomass. These initiatives represent a new generation of sustainable advanced materials aligned with industrial decarbonization and circular economy principles.

​

Nanotechnology

 

Bionanotechnology

​

Biotechnology

​​​

International Research Investment Opportunities

​

MAXi's international structure creates unique opportunities for cross-border research investment.

Projects developed in Brazil may receive strategic support from international partners, investors and institutions operating through the United States and Portugal.

​

Likewise, technologies, intellectual property and innovation programs originating in Europe or North America can be jointly developed, validated and industrialized through MAXi's Brazilian operations and research network.

​

This model enables:

• International co-development programs

• Cross-border technology transfer

• Joint intellectual property generation

• Global grant applications

• Public-private innovation partnerships

• Venture creation and spin-offs

• Industrial demonstration projects

• International licensing agreements

​

By connecting scientific talent, infrastructure, funding mechanisms and industrial partners across multiple jurisdictions, MAXi creates an environment where innovation can move seamlessly across borders.

​

From Research to Commercialization

​

Innovation only creates value when it reaches society.

For this reason, MAXi has developed a technology commercialization strategy focused on transforming research outcomes into sustainable business opportunities.

​

Commercialization pathways include:

• Technology licensing

• Joint ventures

• Industrial partnerships

• Contract research and development

• Proprietary manufacturing routes

• Intellectual property licensing

• Spin-off creation

• Strategic investment programs

• Global market deployment

​

Through this model, technologies developed within the MAXi ecosystem can be adopted by corporations, manufacturers, healthcare organizations and innovation-driven enterprises worldwide.

​

Shaping the Future Through Science

​

The future will be built by organizations capable of connecting science, innovation, industry and global collaboration.

MAXi Technology Group exists to create that connection.

By integrating advanced research, international partnerships, technology transfer and commercialization strategies, we transform scientific discoveries into technologies that improve lives, strengthen industries and generate sustainable economic impact.